Mereo BioPharma Group plc (MAH0) - Total Liabilities

Latest as of December 2025: €5.00 Million EUR ≈ $5.85 Million USD

Based on the latest financial reports, Mereo BioPharma Group plc (MAH0) has total liabilities worth €5.00 Million EUR (≈ $5.85 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Mereo BioPharma Group plc annual equity growth to track the company's year-over-year net asset growth rate.

Mereo BioPharma Group plc - Total Liabilities Trend (2016–2025)

This chart illustrates how Mereo BioPharma Group plc's total liabilities have evolved over time, based on quarterly financial data. See Mereo BioPharma Group plc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Mereo BioPharma Group plc Competitors by Total Liabilities

The table below lists competitors of Mereo BioPharma Group plc ranked by their total liabilities.

Company	Country	Total Liabilities
Financiere Marjos SA PA:FINM	France	€1.22 Million
Poulaillon SA PA:ALPOU	France	€51.50 Million
Fridenson TA:FRDN	Israel	ILA185.56 Million
Denge Yatirim Holding AS IS:DENGE	Turkey	TL576.37 Million
Pritika Auto Industries Limited NSE:PRITIKAUTO	India	Rs2.69 Billion
InspireMD Inc NASDAQ:NSPR	USA	$12.85 Million
CItech Co Ltd KO:004920	Korea	₩30.28 Billion
Ecoplastic Corporation KQ:038110	Korea	₩1.42 Trillion

Liability Composition Analysis (2016–2025)

This chart breaks down Mereo BioPharma Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Mereo BioPharma Group plc (MAH0) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mereo BioPharma Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mereo BioPharma Group plc (2016–2025)

The table below shows the annual total liabilities of Mereo BioPharma Group plc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€5.00 Million ≈ $5.85 Million	-67.57%
2024-12-31	€15.42 Million ≈ $18.03 Million	-3.39%
2023-12-31	€15.96 Million ≈ $18.66 Million	-39.10%
2022-12-31	€26.21 Million ≈ $30.64 Million	-31.77%
2021-12-31	€38.41 Million ≈ $44.91 Million	-50.70%
2020-12-31	€77.92 Million ≈ $91.09 Million	+68.68%
2019-12-31	€46.19 Million ≈ $54.00 Million	+33.87%
2018-12-31	€34.51 Million ≈ $40.34 Million	+1.93%
2017-12-31	€33.85 Million ≈ $39.58 Million	+350.87%
2016-12-31	€7.51 Million ≈ $8.78 Million	--

About Mereo BioPharma Group plc

F:MAH0 Germany Biotechnology

Market Cap

$54.12 Million

€46.29 Million EUR

Market Cap Rank

#23504 Global

#2053 in Germany

Share Price

€0.29

Change (1 day)

+8.21%

52-Week Range

€0.20 - €1.96

All Time High

€4.48